Cell & Gene Therapy and Connected Health
This initiative recognizes Greater Philadelphia’s leadership in several of the fastest-growing subsectors of the health care industry and is designed to leverage our specialized assets to accelerate growth. It prioritizes Greater Philadelphia being recognized as the global hub of research, talent, capital, and companies in cell & gene therapy, gene editing, and connected health.
Cell & Gene Therapy and Connected Health
This initiative recognizes Greater Philadelphia’s leadership in several of the fastest-growing subsectors of the health care industry and is designed to leverage our specialized assets to accelerate growth. It prioritizes Greater Philadelphia being recognized as the global hub of research, talent, capital, and companies in cell & gene therapy, gene editing, and connected health.
ABOUT THE INITIATIVE
Launched in January 2019, the Cell & Gene Therapy and Connected Health Initiative is supported by 11 partner companies, institutions, and universities in the Greater Philadelphia region. It is focused on the following:
- Shared Storytelling to build awareness of the region’s assets and attract talent, capital, and companies
- Development of Critical Infrastructure to ensure smooth transitions from concepts to products
- Talent Assessment, Attraction, and Training to proactively address workforce needs as the industry scales
- Building a Scalable Ecosystem that supports growing and retaining companies, innovators, and expertise in the region.
The Greater Philadelphia region saw an almost 500 percent increase in venture capital funding in the last 18 months – contributing to the success of six FDA approved therapies with research origins from the region.
ABOUT THE INITIATIVE
Launched in January 2019, the Cell & Gene Therapy and Connected Health Initiative is supported by 11 partner companies, institutions, and universities in the Greater Philadelphia region. It is focused on the following:
- Shared Storytelling to build awareness of the region’s assets and attract talent, capital, and companies
- Development of Critical Infrastructure to ensure smooth transitions from concepts to products
- Talent Assessment, Attraction, and Training to proactively address workforce needs as the industry scales
- Building a Scalable Ecosystem that supports growing and retaining companies, innovators, and expertise in the region.
The Greater Philadelphia region saw an almost 500 percent increase in venture capital funding in the last 18 months – contributing to the success of six FDA approved therapies with research origins from the region.
News
Discovery Starts with SAPA-GP and Amicus Therapeutics’ Haichen Yang, MD, MA, MBA
Freshly graduated from medical school, Dr. Haichen Yang embarked on her journey to the U.S. With 30 years of experience developing new medicine under her belt, her relentless desire to learn and stay at the [...]
The Chamber’s Annual Meeting Emphasizes Strategic Priorities for the Region
More than 1,200 attendees gathered at the Pennsylvania Convention Center on October 31, 2023, for the Chamber’s 223rd Annual Meeting, one of the region’s largest gatherings of executives, elected officials, business owners, and civic leaders. [...]
Messenger RNA (mRNA) Discovery Earns Penn Pioneers the Nobel Prize
Discovery Starts Here! On October 2, 2023, The Nobel Assembly at Karolinska Institute awarded the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó, Ph.D., an adjunct professor of Neurosurgery at Penn’s Perelman [...]
Toolkit
This toolkit is a living resource centered on Greater Philadelphia’s past, present, and future as a hub for cell and gene therapy and connected health.
The core of the toolkit is a set of key messages and supporting points, which were developed to synthesize the region’s strengths in these areas. These messages are designed to resonate with key audiences including investors, customers, talent, expanding companies, members of the media and others.
These messages can be incorporated into press materials, talking points, website and marketing materials, event signage, social media posts and beyond. Reinforcing these messaging points through varied uses across organizations will help to build a cohesive message about the good work happening in our region in cell and gene therapy and connected health.
DOCUMENTS
INVESTORS
